A detailed history of Wolverine Trading, LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Wolverine Trading, LLC holds 16,500 shares of DVAX stock, worth $227,535. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,500
Previous 21,600 23.61%
Holding current value
$227,535
Previous $240,000 12.5%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$9.93 - $17.44 $100,283 - $176,126
10,099 New
10,099 $104,000
Q3 2021

Nov 12, 2021

BUY
$9.16 - $19.83 $201,913 - $437,112
22,043 Added 178.59%
34,386 $668,000
Q1 2021

May 14, 2021

SELL
$4.57 - $11.18 $16,141 - $39,487
-3,532 Reduced 22.25%
12,343 $115,000
Q4 2020

Feb 12, 2021

BUY
$3.73 - $5.6 $6,098 - $9,156
1,635 Added 11.48%
15,875 $78,000
Q3 2020

Nov 13, 2020

BUY
$4.32 - $11.7 $61,516 - $166,608
14,240 New
14,240 $63,000
Q2 2020

Aug 13, 2020

SELL
$2.94 - $9.1 $43,826 - $135,653
-14,907 Closed
0 $0
Q1 2020

May 11, 2020

BUY
$2.27 - $6.2 $2,365 - $6,460
1,042 Added 7.52%
14,907 $53,000
Q4 2019

Feb 12, 2020

SELL
$3.46 - $6.93 $21,472 - $43,007
-6,206 Reduced 30.92%
13,865 $78,000
Q3 2019

Nov 14, 2019

BUY
$2.69 - $4.85 $12,591 - $22,702
4,681 Added 30.42%
20,071 $71,000
Q2 2019

Aug 20, 2019

SELL
$3.65 - $7.89 $181,602 - $392,559
-49,754 Reduced 76.38%
15,390 $61,000
Q1 2019

May 15, 2019

SELL
$7.08 - $12.09 $43,407 - $74,123
-6,131 Reduced 8.6%
65,144 $476,000
Q4 2018

Feb 14, 2019

BUY
$8.14 - $13.28 $366,861 - $598,516
45,069 Added 171.98%
71,275 $615,000
Q3 2018

Nov 14, 2018

SELL
$11.85 - $16.0 $5,391 - $7,280
-455 Reduced 1.71%
26,206 $325,000
Q1 2018

May 15, 2018

BUY
$14.65 - $19.9 $120,789 - $164,075
8,245 Added 44.77%
26,661 $529,000
Q4 2017

Feb 14, 2018

BUY
$17.3 - $24.08 $128,573 - $178,962
7,432 Added 67.66%
18,416 $344,000
Q3 2017

Nov 15, 2017

BUY
$15.2 - $21.5 $166,956 - $236,156
10,984
10,984 $236,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.74B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.